Insider filing · EIKN
Eikon Therapeutics, Inc.
EIKN · Healthcare · 6 filings in 24 months
ticker →
Column Group IV GP, LP bought $1.0M of Eikon Therapeutics (EIKN)
Executed Sep 3, disclosed Sep 8, 5 days later.
Value, as filed
$1.0M
89,200 sh × $11.56
Executed
Sep 3
the trade date, as filed
Disclosed
Sep 8
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
CL
Column Group IV GP, LP
10% owner
profile →
Column Group IV GP, LP (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in Eikon Therapeutics, Inc. (EIKN). Across 1 priced purchase filing, the average 21-session return was -2.0% from execution and -11.7% from disclosure (delay-adjusted; derived). The largest single filing was $38.1M of EIKN (2,117,760 sh across 3 lots, as filed), executed Feb 6.
The name
EIKNHealthcare · Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Column Group IV GP, LP in EIKN
EIKNPURCHASE
Eikon Therapeutics, Inc.
$38.1M2,117,760 sh across 3 lots
Exec Feb 6
Filed Feb 9 · 9:19 PM ET